Wuxi Vision Pro

Wuxi Vision Pro Ltd., established in 2010 by Dr. Liao Xiugao, operates as a specialized manufacturer of ophthalmic medical devices. The company focuses on the entire lifecycle of its products, from research and development to production and marketing, with a core concentration on intraocular lenses (IOLs). Dr. Liao, also known as Charles X. Liao, PhD, leveraged over two decades of experience in the IOL industry to found the company. His background in designing novel materials, backed by more than 25 patents and the development of nine IOLs currently sold on the market, forms the scientific foundation of the company. He had previously established Lilly Ming International Inc. in Irvine, California, in 2004 to develop and manufacture hydrophobic acrylic materials for IOLs.

The firm is positioned to serve the growing ophthalmic market, particularly addressing the rising incidence of cataracts in China and globally. Its business model revolves around manufacturing and selling these medical devices to the worldwide ophthalmic industry. The product portfolio is comprehensive, including a variety of IOLs such as spheric, aspheric, toric, and multifocal lenses. A key offering is the LEIMING brand of aspheric IOLs, which have received both CFDA approval in China and the CE certificate in Europe. These lenses are crafted from a proprietary high refractive index hydrophobic acrylic material, which was developed in-house and has demonstrated excellent biocompatibility in clinical trials. This material is developed and manufactured at a dedicated facility in Irvine, California.

Wuxi Vision Pro has successfully navigated several funding rounds to fuel its growth and development. The company completed a Series A round in October 2015, raising $6.2 million. This was followed by a Series B round in March 2018, which brought in $12.6 million (RMB 80 million) from investors including Qiming Venture Partners and Ruijian Capital. A later Series C round occurred in December 2020, led by Hillhouse. The company's quality management systems are certified under ISO 13485.

Keywords: ophthalmic medical devices, intraocular lenses, cataract surgery, IOL manufacturer, hydrophobic acrylic material, aspheric IOLs, medical device manufacturing, vision correction, ophthalmology, LEIMING IOL, biocompatible materials, eye care technology, surgical devices, medical optics, China healthcare, Qiming Venture Partners, therapeutic devices, life sciences, medical technology, glaucoma treatment, ophthalmic products